Toxoplasmosis Acquired during Pregnancy: Improved Serodiagnosis Based on Avidity of IgG
|
|
- Melissa Ward
- 6 years ago
- Views:
Transcription
1 691 Toxoplasmosis Acquired during Pregnancy: Improved Serodiagnosis Based on Avidity of IgG Maija Lappalainen, Pentti Koskela, Marjaleena Koskiniemi, Pirkko Ammala, Vilho Hiilesmaa, Kari Teramo, Kari O. Raivio, Jack S. Remington, and Klaus Hedman Department of Virology. Departments I and II ofobstetrics and Gynecology. and Children's Hospital. University ofhelsinki, and National Public Health Institute. Oulu, Finland; Stanford University School ofmedicine and Research Institute. Palo Alto Medical Foundation, Palo Alto. California Serodiagnostic methods were evaluated in prenatal screening for primary Toxoplasma infections acquired during pregnancy in the Helsinki area. Altogether 44,181 sera were obtained consecutively during each trimester from 16,733 mothers. All IgG-containing samples were first examined by a sensitive JL-capture (IgM) ELISA, and positive results were reassessed by IgM immunoblotting and indirect IgM ELISA. An assay measuring the avidity of toxoplasma IgG was used for the first time under screening conditions. Patients suspected to have recent toxoplasmosis were reexamined by IgA ELISA and selectively by the differential agglutination assay (HS/AC test) and IgE ELISA; 16 women with diagnostic increases in IgG titer, 36 with IgM fulfilling strict specificity criteria, and 25 with IgG of low avidity were identified. The measurement of IgG avidity was a highly specific and sensitive method suitable for verification of acute primary Toxoplasma infections during pregnancy. Toxoplasma gondii has a worldwide distribution and causes chronic infection in > 10 9 people. Congenital toxoplasmosis results from primary infection of the mother during pregnancy but, as a rule, not from reactivation of her latent infection [1]. The rate oftransmission from mother to fetus increases from 20%to ~70%with gestational age [1, 2]. Most children with intrauterine infection are initially asymptomatic; by early adulthood, however, the vast majority develop late manifestations such as chorioretinitis or neurologic defects [3-5]. Postnatal serodiagnosis is complicated by interference from transplacentally acquired maternal IgG and by variability in the expression of Toxoplasma IgM during infancy [6, 7]. Advances in the polymerase chain reaction methodology may in the future facilitate the diagnosis of congenital toxoplasmosis [8-10]. Received 22 June 1992; revised 21 September Grant support: Finnish Academy, Finnish Cultural Foundation. Finnish Insurance Institution. Finnish Medical Society Duodecirn, Orion Corporation Research Foundation. Paivikki and Sakari Sohlberg Foundation. Rhone-Poulenc Sante. Rinnekoti Research Foundation. and Sigrid Juselius Foundation. Finland; National Institutes of Health (AI ). Presented in part: II th European Meeting of Immunology. Espoo, Finland. June 1991 (abstract 15-19); 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago. September-October 1991 (abstract 659); International Symposium of Recent DevelopmentsofObstetric, Perinatal. and Childhood Infections, Jerusalem, August The study was done with the approvals of the ethical committees ofboth the Helsinki University Central Hospital and the communities. Reprints or correspondence: Dr. K. Hedman. Department of Virology. University of Helsinki, Haartmaninkatu 3. SF Helsinki. Finland. The Journal of Infectious Diseases 1993;167: by The University of Chicago. All rights reserved /93/ $01.00 On account of the diversity or absence of symptoms, the detection of Toxoplasma infection during pregnancy has to be based not on clinical findings but on maternal serology [11]. However, the conventional single-serum assays do not make a clear distinction between a primary and chronic infection. The tendency of specific IgM to persist for a long time, and even at high levels, has been reported before and is not restricted to pregnancy [12-16]. According to several reports, the demonstration of specific IgA is useful in diagnosis of Toxoplasma infection. Encouraging IgA results have been obtained by using fractionated antigen preparations (P30) or whole parasites, especially in the diagnosis of congenital toxoplasmosis [17-22]. A new approach is to seek antibodies specific for the acute stage of Toxoplasma infection. In the form ofa differential agglutination assay (HSjAC test) or an ELISA using acute stage-specific antigens, this strategy showed promise in the separation of recent infections from those acquired in the distant past [23-25]. The search for specific IgE could be another useful approach in the serodiagnosis of recently infected pregnant women [12, 26]. An assay measuring the antigen-binding avidity (functional affinity) of IgG antibodies against T. gondii was recently developed to separate the low-affinity antibodies produced at an early stage ofinfection from those with a higher binding affinity that reflect past immunity [27, 28]. By this technique, primary infection can be identified using a single serum specimen. Similar IgG avidity tests for other pathogens have shown their value as both a frontline assay and a confirmatory test in distinguishing primary from secondary infections and in assessing the time of the initial antigenic challenge [29-34]. In this study we examine, under large-
2 692 Lappalainen et al. 1ID 1993;167 (March) scale screening conditions, the ability ofthis novel serodiagnostic approach to identify primary Toxoplasma infections acquired during pregnancy. Patients and Methods Patients The study area comprises four subdivisions of the metropolitan area ofhelsinki (Espoo, Helsinki, Kauniainen, and Vantaa), with 820,700 inhabitants. We examined women who became pregnant between 1 January 1988 and 30 June Upon antenatal booking at municipal maternity centers, all pregnant women received written information about this study, with requests to present themselves for voluntary blood tests in the 10th-12th (1st trimester), 20th-22nd (2nd trimester), and 35th-37th (3rd trimester) weeks of pregnancy. The participation rate (donors of ~ I sample) among all pregnant women in the study area was 90.2%. More demographic data are given elsewhere [35]. We obtained 44,181 prenatal sera (from 16,733 mothers); complete sets of 3 sera (samples obtained during each trimester) were obtained from 70.5% of the participants. Women with findings suggesting recent Toxoplasma infection (seroconversion or diagnostic [fourfold or more] increase in IgG, positive IgM, low avidity of IgG) were referred to the Helsinki University Central Hospital for obstetric consultation and treatment. Maternal and cord blood sera were obtained at delivery. Subsequent serum sampling was scheduled for postnatal months I, 3, 6, and 12; these results will be published separately. Methods IgG. The samples of uncitrated cubital venous blood were allowed to clot, and sera were separated by centrifugation and stored frozen. The primary screening test was indirect ELISA (Toxenz-G; Northumbria Biologicals, Cramlington, UK) for Toxoplasma IgG [36]. Sera with ambiguous results were reexamined by another IgG ELISA (Toxoplasma gondii IgG EIA kit; Labsystems, Helsinki). In this assay, specific IgG was quantified by serial dilution ofthe sera to obtain end-point titers with A 405 = as the cutoff. Increase in IgG titer was considered diagnostic when it was fourfold or greater. IgM. In sera containing specific IgG, Toxoplasma IgM was first measured by a highly sensitive [37] wcapture ELISA (Toxenz M II; Northumbria Biologicals). Positive specimens, as well as a similar number ofwcapture-negative samples as a control series, were reexamined by two other IgM tests and by the toxoplasma IgG avidity test. For quantitation of Toxoplasma IgM, we used an indirect ELISA (Toxoplasma gondii IgM EIA kit; Labsystems) that has been shown to be both sensitive and specific [38, 39]. Before the assay, all sera were depleted of IgG according to the directions ofthe manufacturer. Single dilutions of sera were placed in microtiter wells in duplicate, and results were expressed as EIA units relative to standard sera: ~40 = IgM-positive; = borderline; <20 = IgM-negative. Unless otherwise stated, IgM results given here are those obtained by the indirect IgM ELISA. IgM immunoblotting was carried out with antigen (T. gondii RH strain) obtained as described [40]. Briefly, intraperitoneal exudate from infected NMRI mice was filtered; the parasites were pelleted by centrifugation, washed in PBS, and sonicated in H 2 0. Supernatant from centrifugation at 10,000 g (60 min) was run in SDS-PAGE using 12% gels, and the separated proteins were transferred to nitrocellulose. The strips of sensitized nitrocellulose were subsequently treated with 5% defatted milk and 0.2% Triton X-100 in PBS, then with patients' sera at a dilution of 1:50. The bound IgM antibodies were marked with peroxidase-conjugated rabbit anti-human IgM (I: 100; Dakopatts, Glostrup, Denmark) and visualized by diaminobenzidine HCl (100 JLg/mL) plus H (0.0 I%). The criterion for positivity was simultaneous staining ofthe protein bands at and 25 kda [41-44]. Among our 79 seronegative controls, none showed an IgM reaction against this doublet ofbands (data not shown). Avidity ofigg. The avidity ofigg specific for T. gondii was measured by a protein-denaturing immunoassay (avidity ELISA) as described [27]. Briefly, serially diluted sera were placed in microtiter wells coated with the T. gondii antigen. After withdrawal ofthe sera, the antibodies attached to the antigen were eluted with a protein denaturant (6 M urea), and the proportion of residual to total antigen-bound IgG was quantified immunoenzymatically. During the first year, we used our own preparations of coated microtiter plates, and during the second, commercially coated IgG ELISA plates (Labsystems). The two preparations gave similar results. IgG avidity results ~15% were considered low; 16%-25%, borderline; and >25%, high. An increase in avidity in paired samples (within 200 days) was considered significant if it was simultaneously twofold or more and of ~ 10% in magnitude. The reproducibility ofthe avidity assay was evaluated by two pools of 5 sera. Pool A contained samples drawn during the acute phase of primary toxoplasmosis, and pool B, sera representing past immunity [27]. The interassay reproducibility was calculated from the results of45 successive "field" experiments during 5 months: the mean IgG avidity results in pools A and B were 10.5%and 49.8%,respectively, and the coefficients of variation were.20 and.15. For intraassay reproducibility, 10 parallel examinations were done. The respective coefficients ofvariation were.16 and.10. IgA andige ELISA andhs/ac test. We determined specific IgA antibodies from the mothers with suspected primary toxoplasmosis during pregnancy by a commercial double-sandwich EIA using the P30 antigen of T. gondii (Toxo A Ab EIA; Clonatee, Paris). The results in this test are expressed as IgA indices: >.70 = positive, = borderline, and <.50 = negative. IgE ELISA [12, 26] and the HS/AC test for acute stage-specific IgG antibodies [24, 25] were done at the Research Institute, Palo Alto Medical Foundation. Results The first screening test was a sensitive Toxoplasma IgG ELISA. Among 3178 IgG-positive women, the sensitive p, capture ELISA gave a positive IgM result for 226 women, who were all studied further. In the indirect IgM ELISA,
3 JID 1993;167 (March) Serodiagnosis of Toxoplasmosis during Pregnancy 693 Table 1. Persistence of Toxoplasma IgM (indirect ELISA) , Time after first IgM-positive 50 sample No. of 40 Group pregnancies 6 months 12 months IgG seroconverters 10 3/10 (30) 2/10 (20) IgG avidity ~ I5% II 6/10 (60) 5/10 (50) IgG avidity> 15% 15 10/13(77) 11/13 (85) Total 36 19/33 (58) 18/33 (55) "#. 30 ~ Cl ~ 20 NOTE. Data are no. with Toxoplasma IgM/no. followed (%). only 36 of the J,L-capture-positive women were positive. For these, immunoblotting confirmed that the IgM ELISA reactions were specific for toxoplasmic proteins (bands of35 and 25 kda). Among the 240 J,L-capture-negative (IgO-positive) controls, 8 (3%) were positive in IgM immunoblotting. We had complete sets of 3 sera during pregnancy from 88 subjects who were IgM-positive during the first trimester by J,L-capture ELISA. The third-trimester sera of these women, obtained on average 24 weeks after the first-trimester samples, were still positive by J,L-capture ELISA in 80 cases (91%). Of the 36 women positive in the indirect IgM ELISA, 58% maintained this result for 6 months and 55% for 12 months (table 1). All the 240 J,L-capture IgM-negative (IgO-positive) control subjects had high (>25%) avidity of Toxoplasma IgO antibodies. The relationship between IgO seroconversions, positive results in the two IgM ELISAs, and low IgO avidity among the 226 J,L-capture-positive women is illustrated in figure 1. D M(Jl)+ ~M+ ~AVI-! IIGtt Figure 1. In women with suspected primary Toxoplasma infection during pregnancy (n = 42), relationship between IgO seroconversions (ott; n = 13), positive results in both IgM ELiSAs [M+, indirect; M(JL)+, wcapture; n = 36], and low IgO avidity (AVI.; n = 25). Disc areas reflect numbers of women with findings and overlapping indicates concordance between assays TIME OF OBSERVED SEROPOSITIVITY (DAYS) Figure 2. Maturation of toxoplasma IgO avidity after IgO seroconversion (n = 13). IgG Seroconverters IgM. Of3178 seropositive women, 13 had IgO seroconversions (no IgO in the first sample). They all became IgMpositive in J,L-capture ELISA. By indirect ELISA, 10 seroconverters (76%) turned IgM-positive, 2 had borderline results, and 1 remained negative. The IgM-negative sample had been taken 13 weeks after the preceding IgO-negative sample. Among the IgM-positive IgO seroconverters, 20% had IgM by indirect ELISA after 12 months (table 1). Avidity ofigg. Of the seroconverters, 11 (85%) had low and 2 had borderline avidity in their first IgO-containing samples (figure 2). The 2 sera with borderline avidity had been obtained exceptionally late, 15 and 27 weeks after the IgO-negative sera. Of the low-avidity sera, 10 had been collected shortly (~ 13 weeks) after the preceding IgO-negative sera and 1 after a 32-week interval. Among the women with low avidity after IgO seroconversion, 10 (91%)reached borderline or high levels by 6 months after the first seropositive sample (figure 2). The avidity of I seroconverter continued to be low until her last sample, taken 11 months after seropositivity was observed. A significant increase in IgO avidity was encountered in 77%of the serocon verters. IgA. Altogether 100 serum samples from the 13 patients with IgO seroconversion during pregnancy were tested by IgA ELISA. All 13 became IgA positive (mean IgA index [±2 SD], 2.1% [±3.6%]). After 6 months of follow-up, 10 (77%), and after 12 months, 9 (69%) still had IgA. Women with Initially Low Avidity of IgG Avidity ofigg. Among the 226 wcapture IgM-positive women, 25 had low (~15%) avidity of IgO: 11 of the seroconverters plus 14 initially IgO-positive women, ofwhom 3 (patients 1, 6, and loin table 2) had significant (fourfold or
4 694 Lappalainen et al. lid 1993; 167 (March) , ~30 ~ C1 :> < DAYS Figure 3. Maturation of initially low (~15%) Toxoplasma IgO avidity (n = 14). *, Toxoplasma IgO disappeared within 6 months. more) increases in IgG titer. Among these 14 initially seropositive subjects with low avidity, II could be followed for at least 6 months: 9 gained borderline avidity within 3 months and I by 10 months (figure 3). The other patient lost reactivity in Toxoplasma IgG ELISA before delivery, at an avidity of II.7% (figure 3), but continued to express a high level of Toxoplasma IgM. A significant increase in IgG avidity occurred in 79% of the initially seropositive patients with low avidity. IgM. After a follow-up of 12 months, 50% ofthese subjects still exhibited IgM by the indirect ELISA (table I). IgA. Altogether, 91 sera from the 14 initially seropositive mothers with low avidity ofigg were tested for IgA: 13 women were initially IgA-positive, and I was in the borderline range. The mean IgA index of this group was 2.2% (±4.3%). In this group, the positive IgA finding persisted for 6 months in 10 (83%) of 12 and for 12 months in 7 (58%). The IgA results among IgG seroconvertersand those initially seropositive with low avidity were almost identical. HS/AC test and IgE ELISA. Serum specimens from 13 of the 14 initially seropositive mothers with low avidity were tested with the HS/AC test and IgE ELISA (table 2). The first-trimester sera were used in 12, while only a second-trimester sample was available for I. Each first-trimester sample showed an acute pattern in the HS/AC test, as did the second-trimester sample. The IgE ELISA was positive in 9 (69%) ofthe 13. IgM-Positive Mothers with High or Borderline Avidity of IgG Avidity ofigg. All the initially IgM-positive women with high (or borderline) IgG avidity retained high avidity beyond 6 months offollow-up: No relapses to the diagnostic (low) avidity range occurred. The avidity of2 started at the borderline range and appeared to mature, raising the possibility of recent infection (figure 4). However, our criteria for significance ofavidity maturation were not met by any subject in this group. IgM. Among the IgG- and IgM-seropositive women with initially high or borderline (» 15%) avidity, 85%retained IgM by the indirect ELISA for I year (table I). IgA. We examined 97 sera from 15 IgM-positive mothers with borderline or high IgG avidity. The mean IgA index ofthis group was 1.8% (±4.0%). Altogether, 9 mothers (69%) retained a positive IgA result for 6 months and 8 (62%) for 12 months of follow-up. HS/AC test. Serum specimens from 15 IgM-positive mothers with initially borderline or high IgG avidity were examined with the HS/ AC test. The first-trimester sera were used in 13 mothers, while in 2 only a second-trimester sample was available. Among 12 with initially high avidity, II exhibited nonacute patterns, and 3 mothers with borderline IgG avidity showed acute patterns in the HS/AC test. One mother with initially high avidity had an acute HS/AC pattern both during pregnancy and also in a follow-up sample obtained 12 months postnatally. Predictive Values of Avidity Results We wanted to assess precisely the predictive values oflowand high-avidity results during early pregnancy. However, since absolute diagnostic criteria for single sera do not exist, we sought the avidity result during the third trimester and determined the serologic status from the first-trimester sample. If the third-trimester sample was missing, the result at delivery was used. Low avidity. There were II women with low IgG avidity during the last trimester, of which 10 were IgG seroconverters. The IIth woman had given no first-trimester serum. Her second-trimester sample had IgM in both ELISAs, very low avidity ofigg, and a diagnostic increase in IgG titer. By all available criteria, this woman had had a primary Toxoplasma infection during early pregnancy. The positive predictive value ofa low-avidity result for Toxoplasma infection during --8 months was 100% (11/II ). High avidity. Each ofthe 75 women with high avidity in the last trimester was already seropositive in the first trimester, 71 ofthem with IgG ofhigh (>25%) avidity, I with low, and 3 with borderline. In these subjects, almost halfof whom had been positive by wcapture ELISA, the predictive value of a high-avidity result against toxoplasmosis within 5 months (the average interval between the first- and third-trimester samples) was 100% and within 8 months (from conception to the third-trimester sample), --95% (71/75). Discussion Specific IgG of low avidity proved to be an excellent single-serum indicator of recent primary Toxoplasma infection,
5 JIO 1993;167 (March) Serodiagnosis of Toxoplasmosis during Pregnancy 695 Table 2. Serologic findings in 14 mothers with initially low avidity of IgG. Patient, IgG Avidity day titer WIgM IgM* IgA HS/AC (%)t IgE 1, Acute NO + + Acute 10.4 NO 2, Acute NO + + NO 28.4 NO NO + + NO 49.8 NO 3, /- Acute Not acute 11.7 NO 202 <200 NO + NO NO 4, /- + Acute NO +/- + NO 11.9 NO /- NO 14.0 NO 5, Acute NO + + NO 28.5 NO NO + + NO 43.3 NO 6, NO 6.6 NO /- + Acute Not acute 21.1 NO NO + NO 41.4 NO 7, Acute /- + Acute 18.8 NO NO + NO 31.1 NO 8, Acute 11.0 NO Acute NO 21.2 NO NO + + NO 25.0 NO 9, NO Acute NO + Not acute 26.4 NO NO + NO 31.8 NO 10, Acute 1.8 NO Acute /- + NO 6.6 NO NO + + NO 30.6 NO 11, Acute 14.3 NO Acute NO NO 21.0 NO NO NO 36.4 NO 12, NO 15.0 NO NO +/- + NO 43.7 NO NO +/- NO NO 29.3 NO 13, Acute NO 32.0 NO NO + NO 36.9 NO 14, Acute /- NO NO 24.0 NO NO + NO 43.6 NO NOTE. NO = not done; +/- = borderline. * Indirect IgM ELISA. t Ratio (%) of end-point titers (with/without urea elution). as already suggested by previous studies [27, 45]. Under our demanding screening conditions, its positive predictive value was 100%, as assessed by the third-trimester sera coupled to retrieval of the first-trimester antibody status. This serodiagnostic marker also had a high sensitivity, intermediate between the two IgM ELISAs. With the avidity technique we were able to show that among women presenting with Toxo- plasma IgM at the time ofpregnancy, a high proportion had not actually been infected recently. Concerning the role of IgM, most investigators would agree that the most telling detection of IgM antibody by a sensitive test is its absence: A woman with IgG but without IgM is extremely unlikely to have acquired toxoplasmosis recently [I]. Since specific IgM antibodies may be detectable
6 696 Lappalainen et al. lid 1993;167 (March) ~ 30 ~ Cl ~ DAYS Figure 4. Follow-up of Toxoplasma IgG avidity in Toxoplasma IgM-positive mothers with high or borderline initial avidity (n = 15). in both the acute and chronic phases of toxoplasmosis, the need for confirmatory evidence ofan acute infection is crucial. So far the retrospective diagnosis of recently acquired Toxoplasma infection in non symptomatic individuals has been difficult because of the lack of reliable single-serum techniques. An accurate result is particularly important for pregnant women: The diagnosis must be made early so that appropriate therapeutic decisions can be made. Because the level ofspecific IgG antibodies as such is an unreliable indicator of recent infection [I], mothers presenting with antibodies in their first sample are the greatest challenge in diagnosis and therapy. In our study, each individual who had low-avidity IgG was a seroconverter or HSjAC-positive. The 14 initially seropositive women with low avidity in the first sample resembled the IgG seroconverters closely in three important features: IgM and IgA profiles and maturation of IgG avidity. The avidity ELISA, in contrast to the IgM and IgA ELISAs, was able to distinguish acute from chronic Toxoplasma infections; in our sera, IgA (p30 antigen) de facto persisted longer than did IgM by the least sensitive assay. There were 16 patients with infection during pregnancy verified by seroconversion or a diagnostic increase in IgG titer compared with II seropositive patients without such markers but with initially low avidity. Besides the antibody profiles, these numbers of patients support the conclusion that women in both groups had acquired Toxoplasma infections recently: Because our sequential sera spanned only the period between the first- and lasttrimester samples, diagnostic increases in antibody titer occurring during early pregnancy would have been missed by conventional IgG serology. On the other hand, the IgG avidity test should cover not only the intersample period but also the preceding weeks during early pregnancy. If the disease is rare, even a highly specific screening test will yield false-positive results, perhaps more often than correct diagnoses [46]. Therefore, it would be hazardous to screen large populations of asymptomatic individuals with any single test for a diagnosis such as toxoplasmosis that could necessitate long-term medication during pregnancy or abortion. To minimize such errors, we used a combination of assays. In general, the purpose ofthe first, sensitive assay is to select a study group of reasonable size that still includes all suspects. The second, confirmatory test has to be specific. For the latter purpose, measurement ofigg avidity was suitable because it had a very high sensitivity and excellent specificity, superior to any IgM assay tested. To identify each subject with conventional markers of infection, we positioned the avidity assay behind the IgG and IgM tests. Because the avidity test is dependent on the presence ofantibody of the IgG class, the paucity ofspecific IgG during very early illness would favor the simultaneous examination for specific IgM. Moreover, even as a straightforward modification ofindirect ELISA [27], the avidity ELISA consumes more antigen (eight wells per sample) and was more cost-effective after a simple, highly sensitive screening test. In the light of our results, we recommend as primary tools in the first trimester an IgG assay in combination with a sensitive IgM test. The role of the IgG avidity result is to confirm (low avidity) or dispute (high avidity) the diagnosis. Follow-up of seronegative women could be based primarily on IgG serology. For the initially seropositive mothers with low avidity, additional evidence for infection during early pregnancy can be obtained by increases in the titer or avidity of IgG. Acknowledgments We thank Susanna Aro, Lea Hedman, Helena Matikainen, and Teija Tekkala for expert technical assistance, Heikki Isotalo and Heikki Lehvaslaiho for help in computerizing the data, and Jean Margaret Perttunen and Ross Stephens for revising the manuscript. References I. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS. Klein JO. eds. Infectious diseases of the fetus and newborn infant. 3rd ed. Philadelphia: WB Saunders. 1990: Frenkel JK. Toxoplasmosis. Symposium on parasitic infections. Pediatr Clin North Am 1985;32: Koppe.IG, Loewer-Sieger DH. de Roever-Bonnet H. Results of20-year follow-up ofcongenital toxoplasmosis. Lancet 1986; I : Wilson CB. Remington JS. Stagno S. Reynolds OW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980;66: Sever JL. Ellenberg JH, Ley AC, et al. Toxoplasmosis: maternal and pediatric findings in pregnancies. Pediatrics 1988;82: Daffos F. Forestier F. Capella-Pavlovsky M, et al. Prenatal management of746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318:271-5.
7 JID 1993;167 (March) Serodiagnosis of Toxoplasmosis during Pregnancy Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1985;1: Burg JL, Grover CM, Pouletty P, Boothroyd JC, Direct and sensitive detection ofa pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989;27: Savva 0, Morris J'C,Johnson JD, Holliman RE. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol 1990;32: Dupouy-Camet J, desouza SL, Bougnoux ME, et al. Preventing congenital toxoplasmosis [letter]. Lancet 1990;2: II. Antenatal screening for toxoplasmosis in the UK [editorial]. Lancet 1990;2: Pinon JM, Thoannes H, Gruson N. An enzyme-linked immuno-fiitration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods 1985;77: Sulzer A, Franco EL, Takafuji E, Benenson M, Walls KW, Greenup RL. An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year. Am J Trop Med Hyg 1986;35: Brooks RG, McCabe RE, Remington JS. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis 1987; 9: IS. Herbrink P, van Loon AM, Rotmans JP, van Knapen F, van Dijk We. Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J C1in MicrobioI1987;25: Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J C1in Microbiol 1989;27: Turunen H, Vuorio KA, Leinikki PO. Determination of lgg, IgM and IgA antibody responses in human toxoplasmosis by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis 1983; 15: Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosisof acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162: Decoster A, Caron A, Darcy F, Capron A. IgAantibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet 1988; 2: Pinon JM, Thoannes H, Pouletty PH, PoirriezJ, Damiens J, Pelletier P. Detection ofiga specific for toxoplasmosis in serum and cerebrospinal fluid using non-enzymatic IgA-capture assay. Diagn Immunol 1986;4: Fortier B, Rolland 0, Ajana F, Dubremetz JF, Vernes A. Detection of specific antibodies to Toxoplasma gondii by a competitive enzyme immunoassay using a monoclonal antibody against the P30 antigen. Eur J Clin Microbiol Infect Dis 1991;10: Decoster A, SlizewiczB, Simon J, et al. Platelia-Toxo IgA. a new kit for early diagnosis of congenital toxoplasmosis by detection ofanti-p30 immunoglobulin A antibodies. J Clin Microbiol 1991;29: Suzuki Y, Thulliez P, Remington JS. Use of acute-stage-specific antigens of Toxoplasma gondii for serodiagnosisof acute toxoplasmosis. J Clin Microbiol 1990;28: Dannemann BR, Vaughan We, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 1990;28: Suzuki Y, Thulliez P, Desmonts G, Remington JS. Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of toxoplasma infection in humans. J Clin MicrobioI1988;26: Pinon JM, Toubas 0, Marx C, et al. Detection of specificimmunoglobulin E in patients with toxoplasmosis. J Clin Microbiol 1990; 28: Hedman K, Lappalainen M, Seppala I, Makela O. Recent primary toxoplasma infection indicated by a low avidity ofspecific IgG. J Infect Dis 1989;159: Joynson OHM, Payne RA, Rawal BK. Potential role ofigg avidity for diagnosing toxoplasmosis. J Clin Pathol 1990;43: Hedman K, Seppala I. Recent rubella virus infection indicated by a low avidity ofspecific IgG. J Clin ImmunoI1988;8: Rousseau S, Hedman K. Rubella infection and reinfection distinguished by avidity ofigg [letter]. Lancet 1988; I: Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet 1991; 338: Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 1986;86: Enders G, Knotek F. Rubella IgG total antibody avidity and IgG subclass specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 1989;17: Thomas HIJ, Morgan-Capner P. The use ofantibody avidity measurements for the diagnosis of rubella. Rev Med ViroI1991;1: Lappalainen M, Koskela P, Hedman K, et al. Incidence of primary toxoplasma infections during pregnancy in southern Finland. A prospective cohort study. Scand J Infect Dis 1992;24: Joss AWL, Skinner U, Chatterton JMW, Cubie HA, Pryde JFD, Campbell JD. Toxoplasmosis: effectiveness of enzyme immunoassay screening. Med Lab Sci 1989;46: Joynson OHM, Payne RA, Balfour AH, Prestage ES, Fleck DG. Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody. J Clin Pathol 1989;42: Balfour AH, Harford JP. Detection of specific IgG and IgM antibodies to Toxoplasma gondii with a commercially available enzyme immunoassay kit system. J Clin Pathol 1985;38: Verhofstede C, van Renterghem, Plum J. Comparison of six enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii. J Clin Pathol 1989;42: Partanen P, Turunen H, Paasivuo R, Leinikki P. Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulins G, M, and A antibodies at different stages of infection. J Clin Microbiol 1984;20: Potasman 1, Araujo FG, Thulliez P, Desmonts G, Remington JS. Toxoplasma gondii antigens recognized by sequential samples of serum obtained from congenitally infected infants. J Clin Microbiol 1987;25: Deletoille P, Ovlaque G, SlizewiczB. Advantage of using 35,000-molecular-weight protein for testing of Toxoplasma gondii immunoglobulin M [letter]. J Clin Microbiol 1988;26: Potasman I. Araujo FG, Remington JS. Toxoplasma antigens recognized by naturally occurring human antibodies. J Clin Microbiol 1986;24: Sharma SO, Mullenaux J, Araujo FG, Erlich HA, Remington JS. Western blot analysis of the antigens oftoxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 1983; 131: Camargo ME, da Silva SM, Leser PG, Granato CH. Avidez de anticorpos IgG especificos como marcadores de infeccao primaria recente pelo Toxoplasma gondii. Rev Inst Med Trop Sao Paulo 1991;33: Thorp JM, Seeds JW, Herbert WNP, et al. Prenatal management and congenital toxoplasmosis [letter]. N Engl J Med 1988;319:372-3.
Received 8 April 1996/Returned for modification 19 June 1996/Accepted 15 July 1996
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1996, p. 2526 2530 Vol. 34, No. 10 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Study of Abbott Toxo IMx System for Detection of Immunoglobulin
More informationEffect of Testing for IgG Avidity in the Diagnosis of Toxoplasma gondii Infection in Pregnant Women: Experience in a US Reference Laboratory
1248 Effect of Testing for IgG Avidity in the Diagnosis of Toxoplasma gondii Infection in Pregnant Women: Experience in a US Reference Laboratory Oliver Liesenfeld, 1,2,3 Jose G. Montoya, 1,2 Sandra Kinney,
More informationFalse-Positive Results in Immunoglobulin M (IgM) Toxoplasma Antibody Tests and Importance of Confirmatory Testing: the Platelia Toxo IgM Test
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1997, p. 174 178 Vol. 35, No. 1 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology False-Positive Results in Immunoglobulin M (IgM) Toxoplasma
More informationVIDAS Test for Avidity of Toxoplasma-Specific Immunoglobulin G for Confirmatory Testing of Pregnant Women
JOURNAL OF CLINICAL MICROBIOLOGY, July 2002, p. 2504 2508 Vol. 40, No. 7 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.7.2504 2508.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationDevelopment of Specific Immunoglobulins G, M, and A Following Primary Toxoplasma gondii Infection in Pregnant Women
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1998, p. 2907 2913 Vol. 36, No. 10 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Development of Specific Immunoglobulins
More informationImproved Diagnosis of Primary Toxoplasma gondii Infection in Early Pregnancy by Determination of Antitoxoplasma Immunoglobulin G Avidity
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1997, p. 1972 1977 Vol. 35, No. 8 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Improved Diagnosis of Primary Toxoplasma gondii Infection
More informationEvaluation of the Immunoglobulin G Avidity Test for Diagnosis of Toxoplasmic Lymphadenopathy
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2004, p. 4627 4631 Vol. 42, No. 10 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.10.4627 4631.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationImmunoglobulin M Toxoplasma Antibodies
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, JUlY 1994, p. 401-405 Vol. 1, No. 4 1071-412X/94/$04.00+0 Copyright C) 1994, American Society for Microbiology The Vitek Immunodiagnostic Assay for Detection
More informationMolecular Markers in Acute and Chronic Phases of Human Toxoplasmosis: Determination of Immunoglobulin G Avidity by Western Blotting
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, May 2000, p. 384 389 Vol. 7, No. 3 1071-412X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Molecular Markers in Acute
More informationRole of Specific Immunoglobulin E in Diagnosis of Acute Toxoplasma Infection and Toxoplasmosis
JOURNL OF CLINICL MICROBIOLOGY, Nov. 199, p. 2952-2959 95-117/9/112952-8$2./ Copyright 199, merican Society for Microbiology Vol. 1, No. 11 Role of Specific Immunoglobulin in Diagnosis of cute Toxoplasma
More informationSimplified Assay for Measuring Toxoplasma gondii Immunoglobulin G Avidity
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2001, p. 904 908 Vol. 8, No. 5 1071-412X/01/$04.00 0 DOI: 10.1128/CDLI.8.5.904 908.2001 Copyright 2001, American Society for Microbiology. All Rights
More informationDetection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis
ORIGINAL ARTICLE Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis Josk Gutikrrex, Marla Rodrkuex, Gonxalo Pie drola and Marla del Carmen Maroto Microbiology
More informationagglutination assay (ISAGA) for detecting toxoplasma specific IgM
J Clin Pathol 1989;42:1291-1295 Assessment of immunoglobulin-m immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM KIM T DUFFY, P J WHARTON, JULIE D JOHNSON, LINDA NEW, R E
More informationImmunoglobulin-A detection and the investigation of clinical toxoplasmosis
J. Med. Microbiol. - Vol. 38 (1993), 286-292 1993 The Pathological Society of Great Britain and Ireland Immunoglobulin-A detection and the investigation of clinical toxoplasmosis BINDYA PATEL, YVONNE YOUNG,
More informationReliable screening for early diagnosis
Elecsys TORCH panel Reliable screening for early diagnosis Toxoplasmosis Rubella HSV CMV Toxoplasmosis The safe and sure approach to Toxo screening Ultrasensitive Toxo IgM optimized to detect all potential
More informationComparison of the efficiency of two commercial kits ELFA and Western blot in estimating the phase of Toxoplasma gondii infection in pregnant women
Annals of Agricultural and Environmental Medicine 2016, Vol 23, No 4, 570 575 www.aaem.pl ORIGINAL ARTICLE Comparison of the efficiency of two commercial kits ELFA and Western blot in estimating the phase
More informationLecture-7- Hazem Al-Khafaji 2016
TOXOPLASMOSIS Lecture-7- Hazem Al-Khafaji 2016 TOXOPLASMOSIS It is a disease caused by Toxoplasma gondii which is a protozoan parasite that is infects a variety of mammals and birds throughout the world.
More informationNon-commercial use only
Microbiologia Medica 2017; volume 32:6583 Evaluation of the TGS TA system for the detection of anti-toxoplasma antibodies Olivia Arpino, Annalisa Cianflone, Maria Teresa Manco, Alessia Paganini, Massimo
More informationInnovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationpatient's serum is separated from other serum components by selective absorption of the IgM
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1981, p. 486-491 0095-1137/81/1 10486-06$02.00/0 Vol. 14, No. 5 Immunoglobulin M-Immunosorbent Agglutination Assay for Diagnosis of Infectious Diseases: Diagnosis
More informationOcular Toxoplasmosis - A Laboratory View. Chatterton JMW* Evans R. Ho-Yen DO
Ocular Toxoplasmosis - A Laboratory View Chatterton JMW* Evans R Ho-Yen DO Scottish Toxoplasma Reference Laboratory Microbiology Department Raigmore Hospital Inverness IV UJ * corresponding author Introduction
More informationToxoplasma gondii IgM ELISA Kit
Toxoplasma gondii IgM ELISA Kit Catalog Number KA0226 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationModification and Evaluation of Avidity IgG Testing for Differentiating of Toxoplasma gondii Infection in Early Stage of Pregnancy
Original Article Modification and Evaluation of Avidity IgG Testing for Differentiating of Toxoplasma gondii Infection in Early Stage of Pregnancy Mohammad Reza Bonyadi, M.D. 1 *, Parvin Bastani, M.D.
More informationMethod for Avoiding False-Positive Results Occurring in Immunoglobulin M Enzyme-Linked Immunosorbent Assays
JOURNAL OF CLINICAL MICROBIOLOGY, July 1981, p. 73-78 0095-1 137/81/070073-06$02.00/0 Vol. 14, No. 1 Method for Avoiding False-Positive Results Occurring in Immunoglobulin M Enzyme-Linked Immunosorbent
More informationLaboratory Diagnosis of Toxoplasma gondii Infection and Toxoplasmosis
S73 Laboratory Diagnosis of Toxoplasma gondii Infection and Toxoplasmosis Jose G. Montoya Department of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto,
More informationDetection of Immunoglobulin M Antibodies Specific for Toxoplasma gondii with Increased Selectivity for Recently Acquired Infections
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2004, p. 5705 5709 Vol. 42, No. 12 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.12.5705 5709.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationToxoplasma gondii IgM ELISA Kit
Toxoplasma gondii IgM ELISA Kit Catalog Number KA0226 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationSURVEILLANCE OF TOXOPLASMOSIS IN DIFFERENT GROUPS
SURVEILLANCE OF TOXOPLASMOSIS IN DIFFERENT GROUPS Pages with reference to book, From 183 To 186 Mughisuddin Ahmed ( Department of Pathology, Dow Medical College and Basic Medical Sciences Institute, Jinnah
More informationToxoplasma gondii IgM (Toxo IgM)
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationSignificance of a positive Toxoplasma Immunoglobulin M test result. in the United States
JCM Accepted Manuscript Posted Online 9 September 2015 J. Clin. Microbiol. doi:10.1128/jcm.01663-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Significance of a positive
More informationToxoplasma infection and systemic lupus erythematosus: Analysis of the serological
628 6 Clin Pathol 1993;46:628-632 The Toxoplasma Reference Laboratory, Public Health Laboratory, Leeds I Noel A H Balfour Bacteriology Department, Royal Hallamshire Hospital, Sheffield M H Wilcox Correspondence
More informationUtility of Immunoblotting for Early Diagnosis of Toxoplasmosis Seroconversion in Pregnant Women
CLINICAL AND VACCINE IMMUNOLOGY, Nov. 2011, p. 1908 1912 Vol. 18, No. 11 1556-6811/11/$12.00 doi:10.1128/cvi.05303-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Utility of
More informationNational Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association between High IgM Antibody Titer and Low IgG Avidity
CLINICAL AND VACCINE IMMUNOLOGY, Nov. 2011, p. 1895 1899 Vol. 18, No. 11 1556-6811/11/$12.00 doi:10.1128/cvi.05228-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. National Prevalence
More informationFinland. In a preliminary report (10), we have described
JOURNAL OF CLINICAL MICROBIOLOGY, June 1983, p. 988-992 0095-11 37/83/060988-05$02.00/0 Copyright C) 1983, American Society for Microbiology Vol. 17, No. 6 Demonstration of Intraocular Synthesis of Immunoglobulin
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(1):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.373
More informationClinical Value of Specific Immunoglobulin E Detection by Enzyme-Linked Immunosorbent Assay in Cases of Acquired and Congenital Toxoplasmosis
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2003, p. 1681 1686 Vol. 41, No. 4 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.4.1681 1686.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationMaternofoetal transfer of Cytomegalovirus IgG antibodies in Maiduguri, North Eastern Nigeria
ISPUB.COM The Internet Journal of Microbiology Volume 9 Number 1 Maternofoetal transfer of Cytomegalovirus IgG antibodies in Maiduguri, North Eastern Nigeria T Adisa, D Bukbuk, T Harry Citation T Adisa,
More informationTELEFAX. Toxoplasma Serology Laboratory (TSL) DATE: TO: FAX: FROM:
TELEFAX DATE: TO: FAX: FROM: Toxoplasma Serology Laboratory RE: SPECIMEN REQUIREMENTS AND TESTING INFORMATION (effective 1/15/16) THIS TRANSMISSION CONSISTS OF 16 PAGES INCLUDING THIS COVER PAGE. IF THERE
More informationIgG Antibodies To Toxoplasma Gondii ELISA Kit Protocol
IgG Antibodies To Toxoplasma Gondii ELISA Kit Protocol (Cat. No.:EK-310-85) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED
More informationan antirubella antibody labelled with iodine-125 not require purified rubella antigen and, in general, are resistant to false positive results due to
J Clin Pathol 1985;38:1150-1154 Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM KATHRYN BELLAMY,* J HODGSON,t PS GARDNER,* P MORGAN-CAPNERt
More informationCHEMILUMINESCENCE ENZYME IMMUNOASSAY (CLIA) Toxoplasma IgG. Cat # (20-25 C Room temp.) Volume
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationtoxoplasmosis Laboratory techniques in the investigation of immunocompromised. Cancer patients, (PCR). Clinical and radiological findings
Genitourin Med 1992;68:55-59 Public Health Laboratory Service, Toxoplasma Reference Laboratory, St George's Hospital, Blackshaw Road, London, SW17 OQT, UK K F Barker R E Holliman Address correspondence
More informationCytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy
Infectious Disease Cytomegalovirus IgG, IgM, IgG Avidity II Total automation for accurate staging of infection during pregnancy FOR OUTSIDE THE US AND CANADA ONLY Confidence in Your Results LIAISON Cytomegalovirus
More informationBio-Rad Laboratories. The Best Protection Whoever You Are. Congenital and Pediatric Disease Testing
Bio-Rad Laboratories I N F E C T I O U S D I S E A S E T E S T I N G The Best Protection Whoever You Are Congenital and Pediatric Disease Testing Bio-Rad Laboratories I N F E C T I O U S D I S E A S E
More informationUniversity of Perugia, Experimental Medicine and Biochemical Sciences, Perugia, Italy
REVIEW 10.1111/j.1469-0691.2006.01444.x Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis A. Sensini University of Perugia, Experimental Medicine and Biochemical
More informationAutomated microparticle enzyme immunoassays
238 Infectious Diseases and Immunology, Diagnostic Division, Abbott Laboratories, North Chicago, Illinois 60064, USA J W Safford G G Abbott M C Craine R G MacDonald Correspondence to: J W Safford Abbott
More informationABSTRACT. Introduction
IMPACT OF TOXOPLASMA, RUBELLA, CYTOMEGALO AND HERPES SIMPLEX VIRUSES ON ABORTION PREVALENCE IN WOMEN ATTENDING AZADI TEACHING HOSPITAL IN KIRKUK CITY-2013 Dr. SAMAR KHALEEL-Kirkuk health directorate PR.
More informationShort Video. shows/monsters-inside- me/videos/toxoplasma-parasite/
The word Toxoplasma Originated from the Greek word toxon, which meant "bow." The Latin word toxicum, which meant "poison." The original Greek meaning is the one used for the word Toxoplasma, meaning "bow
More informationPerformance of the BioPlex 2200 flow immunoassay (Bio- Rad) in critical cases of serodiagnosis of toxoplasmosis
CVI Accepts, published online ahead of print on 29 January 2014 Clin. Vaccine Immunol. doi:10.1128/cvi.00624-13 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 3 Performance
More informationChlamydia Trachomatis IgM ELISA Kit
Chlamydia Trachomatis IgM ELISA Kit Catalog Number KA0960 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationSHORT COMMUNICATION. IgG AVIDITY IN THE DIAGNOSIS OF ACUTE ROSS RIVER VIRUS INFECTION
DISEASE MARKERS, VOL. 12, 279-282 (1996) SHORT COMMUNICATION IgG AVIDITY IN THE DIAGNOSIS OF ACUTE ROSS RIVER VIRUS INFECTION JOHN KAPELERIS'\ PETER LOWE", DEBBIE PHILLIPS, DA VID WY ATP, MARISSA BATHAM
More informationJ07 Titer dynamics, complement fixation test and neutralization tests
avllm0421c (spring 2017) J07 Titer dynamics, complement fixation test and neutralization tests Outline titer, antibody titer dynamics complement, complement fixation reaction neutralization tests 2/35
More informationEnzyme-Linked Immunosorbent Assay for Mumps and
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1980, p. 319-323 0095-1137/80/04-0319/05$02.00/0 Vol. 11, No. 4 Enzyme-Linked Immunosorbent Assay for Mumps and Parainfluenza Type 1 Immunoglobulin G and Immunoglobulin
More informationHuman toxoplasmosis in Europe. Parasitology, Paris Descartes University, Cochin Hospital, Paris, France
Human toxoplasmosis in Europe Prof Jean Dupouy-Camet Parasitology, Paris Descartes University, Cochin Hospital, Paris, France Toxoplasma gondii, discovered in 1908, by Nicolle at Institut Pasteur de Tunis,
More informationChapter 4. Antibody detection methods for laboratory confirmation of measles, rubella, and CRS
Chapter 4. Antibody detection methods for laboratory confirmation of measles, rubella, and CRS In this chapter: 4.1 Selection and comparison of EIAs for IgM detection 4.2 Interpretation of IgM results
More informationClinical Evaluation of a Chemiluminescence Immunoassay for Determination of Immunoglobulin G Avidity to Human Cytomegalovirus
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, July 2004, p. 801 805 Vol. 11, No. 4 1071-412X/04/$08.00 0 DOI: 10.1128/CDLI.11.4.801 805.2004 Copyright 2004, American Society for Microbiology. All Rights
More informationChlamydia Trachomatis IgG ELISA Kit
Chlamydia Trachomatis IgG ELISA Kit Catalog Number KA0959 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationFirst Department of Microbiology, School of Medicine, Aristotle University of Thessaloniki, Greece
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01193.x Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years E. Diza, F. Frantzidou, E. Souliou, M. Arvanitidou, G. Gioula and A. Antoniadis
More informationRubella virus IgG ELISA Kit
Rubella virus IgG ELISA Kit Catalog Number KA0223 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationPREDICTIVE VALUE OF LATEX AGGLUTINATION TEST IN SEROLOGICAL SCREENING FOR TOXOPLASMA GONDII
PREDICTIVE VALUE OF LATEX AGGLUTINATION TEST IN SEROLOGICAL SCREENING FOR TOXOPLASMA GONDII Yaowalark Sukthana, Thaiyooth Chintana, Waraporn Supatanapong, Chutatip Siripan, Amorn Lekkla and Rachatawan
More informationINTERNATIONAL JOURNAL CEUTICAL RESEARCH AND
Research Article CODEN: IJPRNK B. V. Ramana, IJPRBS, 2013; Volume 2(4): 253-258 ISSN: 2277-8713 IJPRBS INTERNATIONAL JOURNAL OF PHARMAC CEUTICAL RESEARCH AND BIO-SCIENCE SEROPREVALENCE OF ACUTE TOXOPLASMOSIS
More informationAssessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine
Journal of Virological Methods 130 (2005) 59 65 Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine Rasool Hamkar
More informationCongenital CMV infection. Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara
Congenital CMV infection Infectious and Tropical Pediatric Division Department of Child Health Medical Faculty, University of Sumatera Utara Congenital CMV infection Approximately 0.15 2% of live births
More informationToxo IgG. Principle of the Test. Introduction
Toxo IgG E Principle of the Test The ImmunoComb Toxo IgG test is an indirect solid-phase enzyme immunoassay (EIA). The solid phase is a card with 12 projections ("teeth"). Each tooth is sensitized at two
More informationMycoplasma pneumoniae IgG ELISA Kit
Mycoplasma pneumoniae IgG ELISA Kit Catalog Number KA2260 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle
More informationLongitudinal Studies of Neutralizing Antibody Responses to Rotavirus in Stools and Sera of Children following Severe Rotavirus Gastroenteritis
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Nov. 1998, p. 897 901 Vol. 5, No. 6 1071-412X/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Longitudinal Studies of
More informationHYPERIMMUNOGLOBULIN and CMV- DNAemia IN PREGNANT WOMEN WITH PRIMARY CYTOMEGALOVIRUS INFECTION
HYPERIMMUNOGLOBULIN and CMV- DNAemia IN PREGNANT WOMEN WITH PRIMARY CYTOMEGALOVIRUS INFECTION Giovanni Nigro, Rome, Italy Stuart P Adler, Richmond, VA, USA To avoid fetal rejection (50% allograft) an estrogeninduced
More informationToxoplasmosis: Summary of evidences, a Research line
Toxoplasmosis: Summary of evidences, a Research line José G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School
More informationList Number. Store at 2-8 C. Store at C
E Toxo IgM 9K09-20 B9K090 49-3257/R4 Toxo IgM This package insert must be read carefully prior to use. Package insert instructions must be followed precisely. Reliability of assay results cannot be guaranteed
More informationDirect Agglutination Test for Diagnosis of Toxoplasma Infection: Method for Increasing Sensitivity and Specificity
JOURNAL OF CLINICAL MICROBIOLOGY, June 1980, p. 562-568 0095-1 137/80/06-0562/07$02.00/0 Vol. 11, No.6 Direct Agglutination Test for Diagnosis of Toxoplasma Infection: Method for Increasing Sensitivity
More informationQuestions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection
1 of 5 01/02/2016 20:39 Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection Summary CDC has developed interim guidelines for healthcare providers in the United States
More informationImmunoglobulin M from Immunoglobulin G Antibodies
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1980, p. 336-342 0095-1 137/80/09-0336/07$02.00/0 Vol. 12, No. 3 Diagnostic Significance of Immunoglobulin M Antibodies to Toxoplasma gondii Detected After Separation
More informationEtiology. only one antigenic type. humans are its only known reservoir
Rubella( German meas sles ) Etiology Togaviridae family --- genus Rubivirus single-stranded RNA enveloped virus, Its core protein is surrounded by a single-layer lipoprotein envelope with spike-like projections
More informationSerology and International units
Serology and International units L. Grangeot-Keros, National Reference Laboratory for Rubella, Virology Department, A. Béclère Hospital, Clamart, France Detection of rubella-specific IgG antibody Assays
More informationEvaluation of IgG Avidity for Diagnosis of Acute Toxoplasma gondii Compared to Nested PCR in Pregnant Women in First Trimester
Journal of Advances in Medicine 3(1), 31-41, June 2014 3 DOI No. 10.5958/2319-4324.2014.01121.3 Evaluation of IgG Avidity for Diagnosis of Acute Toxoplasma gondii Compared to Nested PCR in Pregnant Women
More informationE. Histolytica IgG ELISA Kit
E. Histolytica IgG ELISA Kit Catalog Number KA3193 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationRubella Latex Agglutination Test
Rubella Latex Agglutination Test Cat. No.:DLAT1088 Pkg.Size:30T Intended use The Rubella Latex Agglutination Test is a rapid latex particle agglutination test for the qualitative and semi-quantitative
More informationZika Virus. Robert Wittler, MD
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationZika Virus. Disclosure. Zika Virus 8/26/2016
Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME
More informationHSV-1 IgM ELISA. Catalog No (96 Tests) For Research Use Only. Not for use in Diagnostic Procedures.
For Research Use Only. Not for use in Diagnostic Procedures. INTENDED USE The GenWay, Inc. HSV-1 IgM ELISA Kit is intended for the detection of IgM antibody to HSV-1 in human serum or plasma. SUMMARY AND
More informationVZV IgG ELISA Catalog No (96 Tests)
INTENDED USE For Research Use Only. Not for use in Diagnostic Procedures. The GenWay, Inc. Kit is intended for the detection of IgG antibody to VZV in human serum or plasma. SUMMARY AND EXPLANATION Varicella
More informationDirect Antiglobulin Test (DAT)
Exercise 8 Direct Antiglobulin Test (DAT) Objectives 1. State the purpose for performing the DAT. 2. State what a positive DAT indicates. 3. List the reagents which are used for performing the DAT. 4.
More informationToxoplasma gondii Antigenic Component p35000 by Enzyme-Linked Antigen Immunosorbent Assay
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1986, p. 1045-1049 0095-1137/86/121045-05$02.00/0 Copyright C) 1986, American Society for Microbiology Vol. 24, No. 6 Demonstration of Immunoglobulin M Class Antibodies
More informationVOL 13, NO 1, JANUREY 2015 SUPPL AL-AZHAR ASSIUT MEDICAL JOURNAL
AL-AZHAR ASSIUT MEDICAL JOURNAL DIAGNOSTIC TESTS TO DETECT RECENT INFECTIONS WITH TOXOPLASMA GONDII IN PREGNANT WOMEN Anwar Hosainy Abo Hashim 1 and Afaf Abdel-Ghany Attya 2 Department of Parasitology,
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationContribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria.
Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria. Hajira Berredjem 1,2, Hayette Aouras 3, Meriem Benlaifa 2, Imène
More informationRecognition of tissue cyst-specific antigens in reactivating toxoplasmosis
J. Med. Microbiol. - Vol. 46 (1997), 587-595 0 1997 The Pathological Society of Great Britain and Ireland SE RO LOG I CAL AND M 0 LECU LAR D IAG N 0s IS Recognition of tissue cyst-specific antigens in
More informationCLINICAL AUDIT SUMMARY CLINICAL AUDIT SUMMARY. Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland
Regional Virology Issue Date: 08/09/14 Page(s): Page 1 of 6 1.0 Name of audit Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland 2.0 Personnel involved Peter Coyle, Han Lu, Daryl
More informationHIV Diagnostic Testing
In The name of God HIV Diagnostic Testing By : Dr. Shahzamani PhD of Medical virology Purpose of HIV Testing To identify asymptomatic individuals To diagnose HIV infection in those who practice high risk
More informationParvovirus B19 Infection in Pregnancy
Parvovirus B19 Infection in Pregnancy Information Booklet Contents THE VIRUS page 3 CLINICAL MANIFESTATIONS page 6 DIAGNOSIS page 8 PATIENT MANAGEMENT page 10 REFERENCES page 12 Parvovirus B19 Infection
More informationComplicated viral infections
Complicated viral infections Clinical case discussion Diagnostic dilemmas NSW State Reference Laboratory for HIV St Vincent s Hospital Sydney Diagnostic dilemmas Indeterminate or discordant serology (western
More informationParvovirus B19 Infection in Pregnancy
Parvovirus B19 Infection in Pregnancy Information Booklet Contents The Virus page 3 Clinical Manifestations page 6 Diagnosis page 8 Patient Management page 10 References page 12 Parvovirus B19 Infection
More informationSeroreactivity to and Avidity for Recombinant Antigens in Toxoplasmosis
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Aug. 2005, p. 977 982 Vol. 12, No. 8 1071-412X/05/$08.00 0 doi:10.1128/cdli.12.8.977 982.2005 Copyright 2005, American Society for Microbiology. All Rights
More informationCriteria for the Use of CMV Seronegative Blood
Cx i Hc^jk^eui^xU j00$\ E. Dayan Sandler, MD Resident IV May 1988. Criteria for the Use of CMV Seronegative Blood Cytomegalovirus (CMV) is one of the herpes family of viruses with a very high worldwide
More informationRole of Serology in the Diagnosis of Toxoplasmic Lymphadenopathy
REVIEWS OF INFECTIOUS DISEASES VOL. 9, NUMBER 4 JULY-AUGUST 1987 1987 by The University of Chicago. All rights reserved. 0162-0886/87/0904-0009$02.00 Role of Serology in the Diagnosis of Toxoplasmic Lymphadenopathy
More informationThe Application of Latent Class Analysis for Diagnostic Test Validation of Chronic Trypanosoma cruzi Infection in Blood Donors
BJID 2002; 6 (August) 181 The Application of Latent Class Analysis for Diagnostic Test Validation of Chronic Trypanosoma cruzi Infection in Blood Donors Dante M. Langhi Junior, José O. Bordin, Adauto Castelo,
More informationCytomegalovirus Seroprevalence among Children 1-5 Years of Age in the United States: The National Health and Nutrition Examination Survey,
CVI Accepts, published online ahead of print on 17 December 2014 Clin. Vaccine Immunol. doi:10.1128/cvi.00697-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Cytomegalovirus
More informationOB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program
OB Provider Guide to Alaska s Perinatal Hepatitis B Prevention Program Dear Colleague, This letter is to introduce myself and explain the role I play with the Alaska Perinatal Hepatitis B Program. Alaska
More informationEnzyme-Linked Immuno-Sorbent Assay for Detection of Measles Virus-Specific Immunoglobulin M Antibody
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1992, p. 564-569 Vol. 30, No. 3 0095-11371921030564-06$02.00/0 Copyright 1992, American Society for Microbiology Performance and Reliability of the Enzygnost Measles
More information